
CERS
Healthcare · Medical Devices · $400.9M market cap
$1.99+0.04 (+2.3%)Nov 13, 4:22 PM EST
Latest report
After the close
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2026
EPS trend, 90 days to now · 30-day revisions 0 up, 0 down
Beat estimates in 2 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 2, 2026 | After the close | -0.01 | -0.00 | +73.0% |
| Jul 30, 2026 | After the close | -0.01 | -0.01 | 0.0% |
| Apr 30, 2026 | After the close | -0.04 | -0.01 | +75.0% |
| Feb 19, 2026 | Time not confirmed | -0.01 | -0.01 | -33.3% |
| Nov 6, 2025 | After the close | -0.02 | -0.00 | +99.5% |
| Aug 5, 2025 | After the close | -0.02 | -0.03 | -50.0% |
| May 1, 2025 | After the close | -0.05 | -0.04 | +20.0% |
| Mar 3, 2025 | After the close | -0.01 | -0.01 | 0.0% |
| Oct 30, 2024 | After the close | -0.03 | -0.02 | +33.3% |
| Aug 1, 2024 | After the close | -0.04 | -0.03 | +25.0% |
| May 2, 2024 | After the close | -0.04 | -0.05 | -25.0% |
| Mar 5, 2024 | After the close | -0.02 | -0.01 | +50.0% |
| Nov 2, 2023 | After the close | -0.05 | -0.03 |
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. The company offers INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The company also offers INTERCEPT Blood…
| +40.0% |
| Aug 2, 2023 | After the close | -0.06 | -0.06 | 0.0% |
| May 4, 2023 | After the close | -0.07 | -0.09 | -28.6% |
| Feb 28, 2023 | After the close | -0.05 | -0.08 | -60.0% |
| Nov 3, 2022 | After the close | -0.05 | -0.05 | 0.0% |
| Aug 4, 2022 | After the close | -0.06 | -0.06 | 0.0% |
| May 5, 2022 | After the close | -0.08 | -0.07 | +12.5% |
| Feb 22, 2022 | After the close | -0.08 | -0.05 | +37.5% |
| Nov 2, 2021 | After the close | -0.10 | -0.07 | +30.0% |
| Aug 3, 2021 | After the close | -0.09 | -0.09 | 0.0% |
| May 4, 2021 | After the close | -0.09 | -0.10 | -11.1% |
| Feb 25, 2021 | After the close | -0.09 | -0.09 | 0.0% |
| Oct 29, 2020 | After the close | -0.10 | -0.08 | +20.0% |
| Aug 4, 2020 | After the close | -0.10 | -0.09 | +10.0% |
| May 5, 2020 | After the close | -0.10 | -0.10 | 0.0% |
| Feb 20, 2020 | After the close | -0.12 | -0.12 | 0.0% |
| Oct 30, 2019 | After the close | -0.12 | -0.13 | -8.3% |
| Aug 1, 2019 | After the close | -0.12 | -0.13 | -8.3% |
| May 7, 2019 | After the close | -0.11 | -0.14 | -27.3% |
| Feb 26, 2019 | After the close | -0.11 | -0.12 | -9.1% |
| Nov 1, 2018 | After the close | -0.10 | -0.11 | -10.0% |
| Aug 2, 2018 | After the close | -0.11 | -0.10 | +9.1% |
| May 8, 2018 | After the close | -0.11 | -0.11 | 0.0% |
| Mar 8, 2018 | After the close | -0.11 | -0.10 | +9.1% |